China’s Vehicle Sales Rise for Fourth Month With Outbreak Easing
(Bloomberg) -- Vehicle sales advanced for a fourth straight month in China, with an easing in the coronavirus pandemic allowing buyers to gradually return to showrooms.
Sales of passenger cars such as sedans and SUVs, as well as commercial vehicles, increased 14.9% in July from a year earlier to 2.08 million units, the China Association of Automobile Manufacturers said in a statement, citing preliminary figures. From January to July, vehicle sales declined by 12.7% to 12.3 million units. CAAM didn't break out numbers for passenger cars or other vehicle types.
Shoppers in the world's largest car market are slowly resuming buying as the government eases restrictions, raising expectations that the auto slump currently in its third year may be nearing an end. Yet challenges remain: ride-hailing apps are reducing the need for personal ownership, and trade tensions with the U.S. threaten China's economic recovery.
The government added stimulus measures such as tax rebates to attract car buyers, while automakers that temporarily suspended operations amid the outbreak now offer generous discounts.
Global carmakers, including Tesla Inc., General Motors Co. and Volkswagen AG, have spent billions of dollars to expand in China and remain undeterred in their efforts to tap the market's long-term growth potential.
Chinese car associations are set to report the final tally for July later this month, including figures specifically for passenger cars. While demand for sedans and SUVs has shown signs of rebound, commercial vehicles such as vans have thus far benefited more from China's economic recovery.
©2020 Bloomberg L.P.
With assistance from Bloomberg
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.